An Obsession That Could Erode Your Portfolio Performance

Aug 29, 2016

In this issue:
» Why It's Best to Avoid Companies Having Huge Promoter Holding Pledged
» Cheap Imports Still a Threat to the Aluminium Industry
» ...and more!
Richa Agarwal, Research analyst

Is absolute price level for a stock a key focus for you when investing? Do you constantly look for past price trends, 52-week lows, and highs when buying and selling stocks?

Well, if you do, you are not alone. Such tendencies have deep roots in psychology. And this one could be attributed to 'anchoring bias' - becoming fixated on past prices and using only that information to make inappropriate investment decisions and ignoring the new developments.

Mind you, there is nothing wrong with buying stocks on correction. But one needs to make sure that the 'correction' is not the only reason for buying. Value investing is not a play on absolute prices. One needs to be ready with the homework - understanding the business and risks, assessing management quality, and having an intrinsic value - before hoping to benefit from the stock price volatility. Most importantly, it requires pricing in the new developments and not getting driven by past story alone. Else what looks like a bargain could turn out to be a falling knife.

Take the case of Cairn India. In March 2014, we recommended investors to Buy at a lower price, post around a 10% correction. The stock price went up post our recommendation...and then fell to correct to near recommended level. Had we recommended to buy the stock then, the loss till date would have been 33%. But we factored in new developments regarding management decisions that seemed against the minority stakeholders' interests and maintained an avoid view.

Similarly, the decision to Sell should not be driven by absolute price levels, else you can lose your winners too early and miss the benefits of compounding.

A case in point is Page Industries Ltd. The stock was recommended under Hidden Treasure in January 2009 at Rs 306 with an initial target price of Rs 630. With strong fundamentals and a growing business, the stock touched the target price in the first year of recommendation. Had we sold the stock then, we would have earned 106%. But the opportunity loss would have been huge. We continued to Hold, keeping in mind the growth prospects.

The disciplined approach has been well rewarded. The stock has turned out to be a 48-bagger for our subscribers!

If a stock seems to be in correction mode, there could be a good reason behind it. And what seems like a dip could be a potential crater. Similarly, a stock in an uptrend might still have significant upside. A 52-week high now could become a 52-week low a year from now. The key is to not lose focus on a stock's value when tracking its price.

If this approach to picking stocks interests, you then I recommend you try my small cap recommendation service- Hidden Treasure. Full details about Hidden Treasure are shared here...

--- Advertisement ---
Crisis in India Is Closer Than You Think...

Bill Bonner and Vivek Kaul, two of the world's most independent thinkers and truth seekers have come together to warn you about a financial crisis.

A crisis that could be as big as the dot-com bust...

And it is headed straight for India!

To find out more about this looming crisis and to get a free copy of Bill Bonner's latest book - Hormegeddon (pay only shipping and handling)... Just click here.

03:10 Chart of the Day

Promoters have been known to pledge their shares on more occasions than not. Is pledging of shares by promoters in itself a bad thing? We think the promoter looking to pledge some shares is fine but a combination of high promoter pledging, rising debt and shaky financials are definitely a cause for concern. The recent past has seen an increasing trend in the pledged shares by the promoter and one has to be extremely wary of such companies. From a universe of the BSE 200 list, these are the top 5 companies which have their promoter holdings pledged big time as per data available till June 2016.

Promoters Pledge It All...

The promoter using pledged shares as a way of raising capital is okay. However, from a small retail shareholder's standpoint, a high amount of pledging with bad financials could lead to the banks or financial institutions (who hold these shares as a collateral) to dump them to recover their dues. This would then have a cascading effect on the stock price as well, resulting in a huge loss for the shareholder.


Metal prices internationally have witnessed a rebound after trading at multi year lows for the whole of 2015. Both industrial and precious metals suffered huge decline in their prices impacting the mining companies adversely. What made the matters worse was overproduction which further exacerbated the industry's problems. Domestically, the aluminium industry faced difficulties in the form of cheap imports from China and other countries.

However, the recent rebound in prices internationally provides some hope for the industry. The worst might just be over. With demand expected to pick up from China, which is one of the largest users of both industrial and precious metals in the near future, prices would likely strengthen further and stabilize. On the demand-supply front, data from the ministry of mines showed a supply deficit of almost 1 million tonnes. While the production remained flat for the year, it was the increase in demand that supported the rise in metal prices. This augurs well for the domestic producers.

There is still a need though to exercise caution since industry data showed rise in aluminium imports by double digits for the period of April-June as compared to last year. Presently, with over 50 percent of the aluminium consumed in India coming through imports, the global situation and domestic measures to protect against a possible flooding of imports are key metrics that need to be monitored.


After opening the day on a flat note, the Indian stock markets continued to trade near the dotted line. At the time of writing, the BSE-Sensex was trading up by about 13 points while the NSE Nifty was trading up by 2 points. Sectoral indices were trading on a mixed note with realty, IT witnessing the maximum selling pressure. While Auto stocks were trading in the green.

04:50 Today's Investing Mantra

"Whether we're talking about socks or stocks, I like buying quality merchandise when it is marked down." - Warren Buffett

This edition of The 5 Minute WrapUp is authored by Richa Agarwal (Research Analyst) and Rohan Pinto (Research Analyst).

Today's Premium Edition.

A Comeback for GSK Pharma?

The stock price of GlaxoSmithKline Pharmaceuticals has witnessed sharp correction. Should one take the plunge?
Read On...Get Access

Recent Articles

All Good Things Come to an End... April 8, 2020
Why your favourite e-letter won't reach you every week day.
A Safe Stock to Lockdown Now April 2, 2020
The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...
One Stock that is All Charged Up for the Post Coronavirus Rebound April 1, 2020
A stock with strong moat is currently trading near 5-year lows.
Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 March 30, 2020
This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

Equitymaster requests your view! Post a comment on "An Obsession That Could Erode Your Portfolio Performance". Click here!

Equitymaster Agora Research Private Limited (hereinafter referred to as "Equitymaster"/"Company") was incorporated on October 25, 2007. Equitymaster is a joint venture between Quantum Information Services Private Limited (QIS) and Agora group. Equitymaster is a SEBI registered Research Analyst under the SEBI (Research Analysts) Regulations, 2014 with registration number INH000000537.

An independent research initiative, Equitymaster is committed to providing honest and unbiased views, opinions and recommendations on various investment opportunities across asset classes.

There are no outstanding litigations against the Company, it subsidiaries and its Directors.

For the terms and conditions for research reports click here.

Details of Associates are available here.

  1. 'subject company' is a company on which a buy/sell/hold view or target price is given/changed in this Research Report.
  2. Neither Equitymaster, Research Analyst or his/her relative have any financial interest in the subject company.
  3. Equitymaster's Associate has financial interest in GSK Pharma.
  4. Neither Equitymaster, it's Associates, Research Analyst or his/her relative have actual/beneficial ownership of one percent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report.
  5. Neither Equitymaster, it's Associates, Research Analyst or his/her relative have any other material conflict of interest at the time of publication of the research report.
  1. Neither Equitymaster nor it's Associates have received any compensation from the subject company in the past twelve months.
  2. Neither Equitymaster nor it's Associates have managed or co-managed public offering of securities for the subject company in the past twelve months.
  3. Neither Equitymaster nor it's Associates have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months.
  4. Neither Equitymaster nor it's Associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months.
  5. Neither Equitymaster nor it's Associates have received any compensation or other benefits from the subject company or third party in connection with the research report.
  1. The Research Analyst has not served as an officer, director or employee of the subject company.
  2. Equitymaster or the Research Analyst has not been engaged in market making activity for the subject company.
Definitions of Terms Used:
  1. Buy recommendation: This means that the subscriber could consider buying the concerned stock at current market price keeping in mind the tenure and objective of the recommendation service.
  2. Hold recommendation: This means that the subscriber could consider holding on to the shares of the company until further update and not buy more of the stock at current market price.
  3. Buy at lower price: This means that the subscriber should wait for some correction in the market price so that the stock can be bought at more attractive valuations keeping in mind the tenure and the objective of the service.
  4. Sell recommendation: This means that the subscriber could consider selling the stock at current market price keeping in mind the objective of the recommendation service.
If you have any feedback or query or wish to report a matter, please do not hesitate to write to us.